WithdrawnNCT00204503
Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
Medication studyAges 18–65United StatesBipolarity
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
- Listed locations
- GalvestonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJune 2003
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- The University of Texas Medical Branch, Galveston
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00204503
- Official title
Show the full official title
An Open Label Pilot Study Evaluating Safety and Efficacy of Divalproex Sodium (Depakote ER) in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence.
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Galveston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The University of Texas Medical Branch, Galveston, a university.
Does this study involve medication?
Yes. The study involves medication, including Depakote ER.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
